Deals Rumor Mill: Valeant, Mubadala, Amtek

By Benjamin Horney (November 1, 2016, 8:11 PM EDT) -- Valeant Pharmaceuticals International Inc. may sell gastrointestinal-drug maker Salix Pharmaceuticals Ltd. to Takeda Pharmaceutical Co. Ltd. for up to $10 billion, according to a Tuesday report from Bloomberg. According to the report, Takeda is one of two suitors vying for the company. The identity of the other bidder was not known, and no timetable for when a deal might occur was disclosed....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!